Member Research and Reports

Member Research and Reports

NYU Professor Co-publishes a New Study on Antihypertensive Medication Adherence in Hispanics

Hypertension affects approximately one-third of the U.S. adults and is a leading risk factor for cardiovascular diseases (CVD), including stroke and heart disease. Studies show that the U.S. Hispanic young adults face the maximum burden of hypertension. While there are numerous treatment regiments for hypertension adherence rates to these treatments remain suboptimal whereby in the U.S. population almost 40 to 50 percent of people diagnosed with hypertension still have uncontrolled high blood pressure. Reasons for this may be due to lack of access, information, or other factors.  Hispanics are the largest growing minority population in the U.S. and have high rates of hypertension and vascular disease.

Dr. Bernadette Boden-Albala, a clinical professor at NYU College of Global Public Health, along with Doctoral Students Ms. Priti Bandi, Ms. Emily Goldmann, and Ms. Nina S. Parikh published a study, “Age-Related Differences in Antihypertensive Medication Adherence in Hispanics: A Cross-Sectional Community-Based Survey in New York City, 2011–2012” in the Preventing Chronic Disease Journal.

Some key findings of the study are:

The study’s findings of low adherence among younger adults are especially concerning given a higher prevalence of uncontrolled hypertension in younger U.S. Hispanics than in other racial/ethnic groups. In addition, this study reports that younger and older adults shared few factors that predicted adherence – arguing against a “one-size-fits-all” approach to improving adherence among different age groups.

Their work in the SEARCH lab continues to identify risk factors and social determinants, which may create disparities by race, ethnicity sex, age, etc., and to develop interventions, which address these novel risk factors.


Tags: , ,